International law firm McDermott Will & Emery represented Enhanced Healthcare Partners in the sale of its interests in SCA Pharmaceuticals, LLC, an FDA-registered outsourcing facility serving over 1,200 hospitals and health systems in the United States, to co-buyers The Vistria Group and Excellere Partners. SCA Pharmaceuticals provides compounded drugs that are otherwise not commercially available, filling a critical void in the pharmaceutical drug landscape.

• This transaction was completed on January 20, 2021.

• McDermott Will & Emery acted as legal counsel to Enhanced Healthcare Partners and its portfolio company SCA Pharmaceuticals, LLC.

• William Blair acted as financial advisor to Enhanced Healthcare Partners and its portfolio company SCA Pharmaceuticals, LLC.

• The McDermott team was led by Kristian Werling and included Karen Gibbs, William Hutchens, Jarrett Szczesny, Patrick McCurry, Kevin Hall, Jeffrey Cassidy and Emily Palmer.

McDermott Will & Emery has over 100 private equity lawyers and is the leading firm ranked by Pitchbook in healthcare private equity by deal volume.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.